Aurisco Pharmaceutical Co Ltd
SSE:605116
Net Margin
Aurisco Pharmaceutical Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 9.5B CNY |
| Net Margin |
22%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 744.3B USD |
| Net Margin |
17%
|
| Country | DK |
| Market Cap | 4T DKK |
| Net Margin |
37%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | US |
| Market Cap | 364.1B USD |
| Net Margin |
45%
|
| Country | US |
| Market Cap | 331.8B USD |
| Net Margin |
4%
|
| Country | UK |
| Market Cap | 187.5B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 189B CHF |
| Net Margin |
20%
|
| Country | CH |
| Market Cap | 182.7B CHF |
| Net Margin |
30%
|
| Country | US |
| Market Cap | 161.7B USD |
| Net Margin |
-1%
|
Profitability Report
View the profitability report to see the full profitability analysis for Aurisco Pharmaceutical Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Aurisco Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 22.1%.
You don't have any saved screeners yet
